Adenosine 3', 5' cyclic monophosphate attenuates the production of fibronectin in the glomeruli of anti-glomerular basement membrane antibody-associated nephritic rats.
1. Excessive production of extracellular matrix is thought to be involved in the progression of glomerulonephritis and glomerulosclerosis. In chronic glomerulonephritis, fibronectin has been shown to accumulate in the glomeruli, accompanied by cell proliferation. 2. Glomerulonephritis was induced in rats by the injection of anti-glomerular basement membrane antibody. The rats showed proteinuria and histological alterations in the glomeruli. An increase in fibronectin levels in the culture medium of isolated nephritic glomeruli was confirmed, and was associated with the development of nephritis. Immunohistochemical staining demonstrated a marked accumulation of fibronectin in the glomeruli of nephritic rats. 3. Attenuated generation of cyclic AMP was also observed in the nephritic glomeruli treated with forskolin, prostaglandin E1 or adenosine. 4. Forskolin, prostaglandin E2 and 8-bromo-cyclic AMP markedly reduced the production of fibronectin by the nephritic glomeruli compared with controls in a dose-dependent manner. 8-Bromo-cyclic AMP suppressed the production of fibronectin by cultured mesangial cells. 5. These findings suggest that the attenuated generation of cyclic AMP in response to ligands is connected to the augmented accumulation of fibronectin in nephritic glomeruli, and may facilitate the development of methods for treating glomerulonephritis and glomerulosclerosis.
Department of Pharmacology, Faculty of Pharmacy, Meijo University 150 Yagotoyama, Tenpakuku, Nagoya 468-8503, Japan. nagamats@ccmfs.meijo-u.ac.jp
Tadashi
T
Nagamatsu
Tsutomu
T
Nishiyama
Isamu
I
Goto
Toshiyuki
T
Nagao
Yoshio
Y
Suzuki
D000818:Animals; D000906:Antibodies / Q000008:administration & dosage / Q000378:metabolism*; D001323:Autoantibodies; D002478:Cells, Cultured; D016895:Culture Media, Serum-Free; D000242:Cyclic AMP / Q000032:analysis / Q000378:metabolism / Q000494:pharmacology*; D005353:Fibronectins / Q000032:analysis / Q000096:biosynthesis* / Q000187:drug effects; D005920:Glomerular Mesangium / Q000166:cytology; D005921:Glomerulonephritis / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology; D007275:Injections, Intravenous; D007678:Kidney Glomerulus / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley
D000906:Antibodies; D001323:Autoantibodies; D016895:Culture Media, Serum-Free; D005353:Fibronectins; C051951:antiglomerular basement membrane antibody; D000242:Cyclic AMP